Navigation Links
Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives
Date:2/20/2008

The MAA is being reviewed under the EMEA's centralized procedure. An authorization from the EMEA would apply to all 27 European Union member states, as well as Norway and Iceland.

The decrease in revenue from collaboration agreement for the current periods compared to the same periods in the previous year is mainly attributable to a change in the estimated period over which the non-refundable upfront payment received from Centocor in respect of eprodisate (KIACTA(TM)) is being amortized.

Reimbursable costs revenue amounted to $64,000 for the current quarter ($396,000 for the year), compared to $178,000 for the same period in the previous year ($712,000 for the year) and consists of costs reimbursable by Centocor in respect of eprodisate (KIACTA(TM))-related activities. The Company earns no margin on these reimbursable costs.

Research and development expenses, before research tax credits and grants, amounted to $12,199,000 for the current quarter ($55,732,000 for the year), compared to $14,142,000 for the same period in the previous year ($51,688,000 for the year). The decrease in the current quarter compared to the same period the previous year is mainly attributable to a reduction in expenses incurred in relation to the development of tramiprosate (ALZHEMED(TM)), primarily in respect of the North American Phase III clinical trial. Also, during the second quarter of 2007, the workforce was reduced due to delay encountered in the product candidate development programs. The increase in the current year compared to the same period the previous year is due to expenses incurred in relation to the development of tramiprosate (ALZHEMED(TM)), primarily in respect of the Phase III clinical trial in Europe and the North American open-label extension of the Phase III study, as well as the conduct of a QT cardiac status Phase I study. For the year ended December 31, 2007, research and development expenses also included costs incurred to support the North A
'/>"/>

SOURCE NEUROCHEM INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine news :

1. Neurochem to present at 2008 BIO CEO & Investor Conference - Presentation will be Web cast live
2. Neurochem appoints Mr. Gary Schmid as CEO of new nutraceutical business
3. Neurochem to present at JPMorgan Healthcare Conference
4. Neurochem announces European opinion for Eprodisate (KIACTA(TM)) for the treatment of AA amyloidosis
5. Neurochem announces eprodisate (KIACTA(TM)) receives acknowledgement of complete response and is granted Class 2 review
6. Neurochem announces departure of Dr. Philippe Calais, President, Global Business
7. Neurochem reports results for third quarter of fiscal 2007
8. Emageon Reports Fourth Quarter and 2007 Financial Results
9. Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program
10. Platinum Underwriters Holdings, Ltd. Reports Record Fourth Quarter and Year Ended December 31, 2007 Financial Results
11. Onyx Pharmaceuticals Reports Fourth Quarter and Twelve-Month 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... York (PRWEB) July 24, 2014 ... ( http://www.injurybeacon.com/granuflo-dialysis/lawsuit/ ) in the U.S. District ... protective order for plaintiff medical information covered by ... According to the July 16th Order, U.S. District ... for Fresenius Medical Care the right to ...
(Date:7/24/2014)... Amy Norton HealthDay Reporter ... sex-crazed teenage boy may be dead wrong, according to a small ... In interviews with 33 boys between the ages of 14 ... with a girl for the closeness and trust. Very few boasted ... starting a relationship with a girl. "In our culture, we ...
(Date:7/24/2014)... HealthDay Reporter THURSDAY, July ... don,t view their kids as unhealthy or recognize the health ... study. The children of the families surveyed for the ... Children,s Hospital in Providence, R.I. "A third categorized their ... Dr. Kyung Rhee, now an assistant professor of pediatrics at ...
(Date:7/24/2014)... found a way to delay or even prevent Alzheimer,s ... the anti-aging protein Klotho can prevent neuron death in ... These findings currently appear in the Journal of ... most frequent age-related dementia affecting 5.4 million Americans including ... more than 40 percent of people over the age ...
(Date:7/24/2014)... 24, 2014 News Facts , ... has achieved certification for compliance with Department of ... by the DoD Information Assurance Certification and Accreditation ... identified within the DoD as the Enterprise Clinical ... designation from the U.S. Army Medical Materiel Agency. ...
Breaking Medicine News(10 mins):Health News:GranuFlo Lawsuits Move Forward in Federal Court, With Issuance of Protective Order for HIPAA Information, Bernstein Liebhard LLP Reports 2Health News:GranuFlo Lawsuits Move Forward in Federal Court, With Issuance of Protective Order for HIPAA Information, Bernstein Liebhard LLP Reports 3Health News:GranuFlo Lawsuits Move Forward in Federal Court, With Issuance of Protective Order for HIPAA Information, Bernstein Liebhard LLP Reports 4Health News:Teenage Boys Want Intimacy, Not Just Sex, Survey Finds 2Health News:Teenage Boys Want Intimacy, Not Just Sex, Survey Finds 3Health News:Parents of Obese Kids Often View Them as Healthy 2Health News:Parents of Obese Kids Often View Them as Healthy 3Health News:BU researchers discover that Klotho is neuroprotective against Alzheimer's disease 2Health News:Perceptive Software Achieves DIACAP Certification for Vendor Neutral Archive Solution to Support U.S. Department of Defense Integrated Clinical Systems Program 2Health News:Perceptive Software Achieves DIACAP Certification for Vendor Neutral Archive Solution to Support U.S. Department of Defense Integrated Clinical Systems Program 3Health News:Perceptive Software Achieves DIACAP Certification for Vendor Neutral Archive Solution to Support U.S. Department of Defense Integrated Clinical Systems Program 4
... way to scan brain tumors and predict which ones will ... ever starts treatment. By linking high water movement in ... 70 percent accuracy which patients, tumors were the least likely ... considers himself lucky. When his aggressive brain cancer returned ...
... , , , , ... Hospital scientists lead survey of genome that identifies new genes ... MEMPHIS, Tenn., Aug. 16 Scientists at St. Jude Children,s Research ... percent of childhood acute lymphoblastic leukemia (ALL), including a gene that may ...
... never met Sumita B. Mitra, Ph.D. But your teeth ... genius has helped restore millions of decayed, broken, or discolored ... a glass make that water, please to toast ... Cadotte. Millions of people might well do exactly that. Mickols ...
... Aug. 16, 2009 Attention all smokeless tobacco users! ... chewing tobacco are safe because they don,t burn and produce ... well-researched tobacco hazards, nitrosamines and nicotine, has discovered a single ... tobacco exposes the user to the same amount of another ...
... July 30, 2009 Pregnant women have a higher incidence ... months due to dehydration, according to a study conducted by ... retrospective population-based study was published in the July issue of ... objective of the study was to determine whether the summer ...
... Comprehensive health reform proposals now before Congress could help ... 19-29 gain coverage, and such reforms would also help ... lose it, according to a new Commonwealth Fund report. ... in Medicaid and a health insurance exchange with a ...
Cached Medicine News:Health News:A crystal ball for brain cancer? 2Health News:A crystal ball for brain cancer? 3Health News:Inherited Risk Factors Increase Odds of Developing Childhood Acute Lymphoblastic Leukemia 2Health News:Inherited Risk Factors Increase Odds of Developing Childhood Acute Lymphoblastic Leukemia 3Health News:Inherited Risk Factors Increase Odds of Developing Childhood Acute Lymphoblastic Leukemia 4Health News:'Heroes of Chemistry' for saving teeth, clean water, new high blood pressure drug 2Health News:'Heroes of Chemistry' for saving teeth, clean water, new high blood pressure drug 3Health News:'Heroes of Chemistry' for saving teeth, clean water, new high blood pressure drug 4Health News:New study expands the list of hazardous chemicals in smokeless tobacco 2Health News:Summer heat increases risk of amniotic fluid level deficiency, Ben-Gurion University study reveals 2Health News:Health reform proposals could help 13 million uninsured young adults gain coverage 2Health News:Health reform proposals could help 13 million uninsured young adults gain coverage 3
(Date:7/24/2014)... CAMPBELL, Calif. , July 24, 2014 /PRNewswire/ ... the development of novel interventional devices to facilitate ... United States Patent and Trademark Office has issued ... core technology behind the company,s Lazarus Cover TM ... The Lazarus ReCover is a single-component stent-retriever ...
(Date:7/24/2014)... 2014 Consolidated Net Profit increased by 43.65 ...   , India Business grew by 20.87% to Rs. ... 4,886.70 Mn Rest of World (ROW) Business grew by ... by 34.53% to Rs. 977.26 Mn Latin America Business ... Glenmark Pharmaceuticals Limited, the research-led global integrated pharmaceutical company, today ...
(Date:7/24/2014)... MEMPHIS, Tenn. , July 24, 2014  In ... time, one in 25 patients has at least one ... and Prevention. What,s more, many of these infections prove ... are causing an alarming number of patient deaths per ... of industry conversation. Consequently, a stronger ...
Breaking Medicine Technology:Lazarus Effect Receives Notice of Allowance for New US Patent Covering Core Protection Technology 2Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 2Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 3Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 4Employees, Equipment and the Environment: Top Infection Prevention Focuses in Hospitals 2Employees, Equipment and the Environment: Top Infection Prevention Focuses in Hospitals 3
... SAN DIEGO , April 26 ADVENTRX Pharmaceuticals, Inc. (NYSE ... reverse stock split is now effective, and the Company,s common stock will ... the market opens today. , , ... The reverse stock split is intended to satisfy the NYSE Amex,s determination, ...
... Israel , April 26, 2010 PolyTouch Medical Ltd., a,leading developer ... LeBlanc , MD, MBA, FACS as Medical Advisor. , ... Dr. Karl LeBlanc , past president ... performed the first,laparoscopic hernia repair in 1991 and has since written three medical ...
Cached Medicine Technology:ADVENTRX Reverse Split Effective; Trading on Adjusted Basis Begins Today 2ADVENTRX Reverse Split Effective; Trading on Adjusted Basis Begins Today 3PolyTouch Medical Ltd. Announces the Appointment of Karl A. LeBlanc, MD, MBA, FACS as Medical Advisor 2PolyTouch Medical Ltd. Announces the Appointment of Karl A. LeBlanc, MD, MBA, FACS as Medical Advisor 3
TEW hooked micro-retractor blade set....
... blades are designed for the retraction of nerves, ... the brain. Equalizes brain retraction pressure. Decreases shear ... Used in conjunction with the Budde Halo Retractor. ... wide and 2 mm and 4 mm wide. ...
Mini-Vise....
The Budde Halo Retractor Side Rail Support is designed for the adaptation and attachment of the Budde Halo Brain Retractor System to the operating room table when a conventional skull clamp is not us...
Medicine Products: